• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型降糖药物:慢性肾脏病患者的考虑因素。

Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.

机构信息

Department of Diabetes and Endocrinology, Derby Hospitals NHS FT, Derby, UK.

出版信息

Nephron Clin Pract. 2014;126(1):14-8. doi: 10.1159/000357680. Epub 2014 Jan 11.

DOI:10.1159/000357680
PMID:24434725
Abstract

One of the commonest complications of type 2 diabetes is renal disease. Treatment guidelines emphasise the need for tight glycaemic control to reduce the development of future complications; however, with the development of renal impairment, the benefit of tight glycaemic control must be weighed against the potential for adverse effects from drugs or their metabolites which may accumulate. In this article, the glucose-lowering drugs used in the management of type 2 diabetes are reviewed, with particular emphasis on newer guidelines and agents.

摘要

2 型糖尿病常见的并发症之一是肾脏疾病。治疗指南强调需要严格控制血糖,以减少未来并发症的发生;然而,随着肾功能损害的发展,必须权衡严格血糖控制的益处与药物或其代谢物可能积聚带来的潜在不良反应。本文回顾了用于 2 型糖尿病管理的降糖药物,特别强调了新的指南和药物。

相似文献

1
Novel hypoglycaemic agents: considerations in patients with chronic kidney disease.新型降糖药物:慢性肾脏病患者的考虑因素。
Nephron Clin Pract. 2014;126(1):14-8. doi: 10.1159/000357680. Epub 2014 Jan 11.
2
Glycemic control of type 2 diabetes mellitus across stages of renal impairment: information for primary care providers.2 型糖尿病患者在肾功能损害各阶段的血糖控制:初级保健提供者的信息。
Postgrad Med. 2018 May;130(4):381-393. doi: 10.1080/00325481.2018.1457397. Epub 2018 Apr 18.
3
[Newer anti - diabetic therapies and chronic kidney disease].[新型抗糖尿病疗法与慢性肾脏病]
G Ital Nefrol. 2017 Jan-Feb;34(1).
4
Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.2型糖尿病合并慢性肾脏病患者安全使用降糖药物的数据概述
Adv Ther. 2015 Nov;32(11):1029-64. doi: 10.1007/s12325-015-0261-x. Epub 2015 Nov 18.
5
Complementing insulin therapy to achieve glycemic control.补充胰岛素治疗以实现血糖控制。
Adv Ther. 2013 Jun;30(6):557-76. doi: 10.1007/s12325-013-0039-y.
6
Combination of the dipeptidyl peptidase-4 inhibitor linagliptin with insulin-based regimens in type 2 diabetes and chronic kidney disease.二肽基肽酶-4抑制剂利格列汀与胰岛素治疗方案联合用于2型糖尿病合并慢性肾脏病的研究
Diab Vasc Dis Res. 2015 Jul;12(4):249-57. doi: 10.1177/1479164115579001. Epub 2015 May 4.
7
Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.治疗肝病患者糖尿病的药代动力学和毒理学考虑因素。
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):839-57. doi: 10.1517/17425255.2014.902444. Epub 2014 Mar 26.
8
Pharmacokinetic considerations for the treatment of diabetes in patients with chronic kidney disease.治疗慢性肾脏病患者糖尿病的药代动力学考虑因素。
Expert Opin Drug Metab Toxicol. 2013 May;9(5):529-50. doi: 10.1517/17425255.2013.777428. Epub 2013 Mar 6.
9
Hypoglycemics for the treatment of type 2 diabetes in patients with chronic kidney disease: a focus on new agents.用于治疗慢性肾脏病患者2型糖尿病的降糖药:聚焦新型药物
CANNT J. 2012 Jan-Mar;22(1):30-6; quiz 37-8.
10
[Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting].[慢性肾脏病中的口服降糖药:临床应用中有哪些局限性]
G Ital Nefrol. 2014 Jan-Feb;31(1).

引用本文的文献

1
Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.在基层医疗中为 2 型糖尿病开具钠-葡萄糖共转运蛋白 2 抑制剂:肾功能和心力衰竭诊断的影响。
Cardiovasc Diabetol. 2021 Jun 28;20(1):130. doi: 10.1186/s12933-021-01316-4.
2
Efficacy and safety of trelagliptin in Japanese patients with type 2 diabetes with severe renal impairment or end-stage renal disease: Results from a randomized, phase 3 study.特立帕肽治疗绝经后妇女骨质疏松症的疗效和安全性:一项随机、双盲、安慰剂对照、多中心临床试验的荟萃分析。
J Diabetes Investig. 2020 Mar;11(2):373-381. doi: 10.1111/jdi.13126. Epub 2019 Sep 19.
3
Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment.
2型糖尿病合并肾功能损害患者使用二肽基肽酶-4抑制剂的系统文献综述
Diabetes Ther. 2016 Sep;7(3):439-54. doi: 10.1007/s13300-016-0189-4. Epub 2016 Aug 8.
4
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies.肾功能损害情况下2型糖尿病的治疗:关于新型疗法我们应了解的内容。
Clin Pharmacol. 2016 Jun 23;8:61-81. doi: 10.2147/CPAA.S82008. eCollection 2016.
5
Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control.慢性肾脏病患者的糖尿病管理:治疗前景与血糖控制
Clinics (Sao Paulo). 2016 Jan;71(1):47-53. doi: 10.6061/clinics/2016(01)08.